VIDEO: CAR T-cell Therapy in CLL (chronic lymphocytic leukemia): Navigating the Landscape and Looking Ahead with Catherine Coombs, MD https://oncologytube.com/car-t-cell-therapy-in-cll-chronic-lymphocytic-leukemia-navigating-the-landscape-and-looking-ahead-with-catherine-coombs-md/ @UCIrvineHealth @_MDEducation @Ryan_fitzpatric
🌟Lazy Sunday Lung Cancer Quiz No 5⃣:
What was the most frequent post-progression regimen after chemo+Amivantamab in MARIPOSA-2?
#some #LCSM @OncoAlert @HeSMO_X @OncoViews
@MedscapeOnc @OncologyTimes @oncologytube @EGFRmNSCLC
Oncology Conference Videos
Oncology News
By: Melinda Telli, MD, Date: 12/9/2023 At the SABCS 2023 conference, we had the privilege…
By: Julie Lang, MD Date. 12/07/2023Julie Lang, MD, a medical professional known for expertise in…
By. Saranya Chumsri, MD Date: 12/12/2023 Saranya Chumsri, MD, an expert in the field of…
In an interview, Andrew Evens, DO, an expert in hematology and oncology, will discuss a…
By. Ruth O’Regan MD Date: 12/07/2023In an interview, Ruth O’Regan MD addresses questions related to the…
Allen Wilbanks stood alongside Alina Hamilton, PhD, at the SABCS 2023 event, where they delved…
In the realm of advancements in CAR T-cell therapy for relapsed/refractory mantle cell lymphoma (MCL),…
By. Joanne Kotsopoulos, MD, Date: 12/07/2023 At the SABCS 2023 conference, Joanne Kotsopoulos, MD, a researcher…
Teclistamab FDA approval biweekly dosing in Relapsed or Refractory Multiple Myeloma (3 KOL Video Interviews…
Jeff Sharman, MD, a medical oncologist at the Willamette Ballet Cancer Institute and Research Center,…
… The Medical Oncology Association of Southern California (MOASC) 2024 Summit has once again set…